Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study

PLoS One. 2015 May 20;10(5):e0126965. doi: 10.1371/journal.pone.0126965. eCollection 2015.

Abstract

Background: The conclusions of population-based studies examining the risk of developing end-stage renal disease (ESRD) after nephrectomy among patients with renal cell carcinoma (RCC) remain inconclusive. In this study, we sought to examine whether patients with RCC undergoing radical nephrectomy (RN) have higher risk of ESRD compared to those undergoing partial nephrectomy (PN).

Methods: Nationwide population-based retrospective cohort of 7670 patients with RCC who underwent RN or PN between 2000 and 2011 as recorded in the Taiwan National Health Insurance in-patient claims data were analyzed. The primary outcome of interest was the occurrence of ESRD requiring regular renal hemodialysis. Multivariable Cox proportional hazard regression model was performed to assess the risk.

Findings: The median follow-up for the post-propensity matched cohort (1212 PN and 2424 RN) was 48 months. Seventy patients (2.9%) developed ESRD among those who underwent RN, for an incidence rate of 6.9 cases per 1000 person-years. In contrast, only 23 patients (1.9%) developed ESRD among patients who underwent PN, for an incidence rate of 5.5 cases per 1000 person-years. Despite the higher incidence rate of ESRD among RN, the aIRR (RN/PN) was 1.26 (95% CI 0.78-2.01), which was not statistically significant.

Conclusions: This Taiwan nationwide population-based study suggests that patients with RCC undergoing RN do not have significantly higher risk of developing ESRD compared to those undergoing PN.

MeSH terms

  • Carcinoma, Renal Cell / surgery
  • Cohort Studies
  • Female
  • Humans
  • Incidence
  • Kaplan-Meier Estimate
  • Kidney Failure, Chronic / epidemiology*
  • Kidney Failure, Chronic / etiology*
  • Kidney Neoplasms / surgery*
  • Male
  • Middle Aged
  • Nephrectomy / adverse effects*
  • Proportional Hazards Models
  • Risk Factors
  • Taiwan / epidemiology

Grants and funding

The authors have no support or funding to report.